45 Followers SGX:T14 - Tianjin ZX USD (USD 0.825) TIANJIN ZHONG XIN PHARM GROUP
Sector: Health Technology, Industry: Pharmaceuticals: Other

Add to WatchList


USD 0.825    -0.010 (-1.20%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Dec 2019


Overview

9 Dec 2019

52 Wk Range: 0.76 - 1.05

Day's Range: 0.825 - 0.835

Last Volume: 71,100

Current Yield: 3.88%

Projected Yield: 3.79%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

9 Dec 2019

Metric T14 S.Median
Beta 0.72 0.18
VaR 18.52 35.44
E.Shortfall 22.89 44.47
Liquidity 57.14K 5,332.93

Fundamental

5 Dec 2019

PE: 7.26

Market Cap: 642M

Price Over Book: 0.881

Price Over Sales: 0.64

Return On Assets: 8.5%

Return On Equity: 12.5%

NAV Over Price: [Friends Only]

General

CEO: Hong Yu

Founded Year: 1992

Headquarters: Tianjin

Employees: 4,642

Shares Outstanding: 768.9M

Security Type: Stock

Useful Links
Homepage

Description

Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups. The company was founded on December 20, 1992 and is headquartered in Tianjin, China.